Eupraxia Pharmaceuticals Inc.

EPRX

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001581178

SEC filings (opens in a new tab)

No open-market purchases or sales by Eupraxia Pharmaceuticals Inc. insiders were filed in the last 90 days; 67 institutions reported holding it in 13F filings for Q2 2026, worth $163.6M in total; no superinvestor holds it.

Q1 2026 vs. Q4 2025

How the institutions holding Eupraxia Pharmaceuticals Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026 All holders in Q4 2025

13F holders of EPRX: Q4 2025 compared with Q1 2026
Measure	Q4 2025	Q1 2026	Change
Holders	36	55	+19
Shares	13.9M	22.5M	+8.56M (+61.3%)
Value	$105.1M	$160.3M	+$55.1M (+52.5%)

New holders (22)

Institutions that held Eupraxia Pharmaceuticals Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to EPRX in Q1 2026
Institution	Shares	Value	% of portfolio
Seven Fleet Capital Management LP	709,515	$5.14M	1.61%
Redmile Group, LLC	700,000	$5.07M	0.34%
Rubric Capital Management LP	691,170	$5.00M	0.06%
Ameriprise Financial Inc	649,074	$4.70M	0.00%
PFM Health Sciences, LP	540,871	$3.92M	0.41%
Woodline Partners LP	440,551	$3.19M	0.01%
Alyeska Investment Group, L.P.	375,000	$2.71M	0.01%
Aisling Capital Management LP	325,000	$2.35M	0.49%
DV Trading LLC	276,000	$2.00M	0.18%
Citadel Advisors LLC	230,176	$1.67M	0.00%
Hudson Bay Capital Management LP	92,347	$668.6K	0.00%
Diadema Partners LP	40,000	$289.6K	0.12%
Persistent Asset Partners Ltd	37,926	$274.6K	0.11%
Toronto Dominion Bank	32,898	$237.5K	0.00%
Axq Capital, LP	15,760	$114.1K	0.01%
Integrated Wealth Concepts LLC	12,000	$86.9K	0.00%
Two Sigma Investments, LP	10,800	$78.2K	0.00%
China Universal Asset Management Co., Ltd.	10,000	$72.4K	0.01%
Morgan Stanley	8,820	$63.9K	0.00%
BNP Paribas Arbitrage, SA	6,429	$46.5K	0.00%
JPMorgan Chase & Co	573	$3.79K	0.00%
Caitong International Asset Management Co., Ltd	1	$7	0.00%

Sold out (3)

Institutions that held Eupraxia Pharmaceuticals Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of EPRX in Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Arrowstreet Capital, Limited Partnership	278,064	$2.09M
Quadrature Capital Ltd	43,186	$325.6K
XTX Topco Ltd	16,180	$122.2K